ARCHIVES

Scientific Misconduct: HHS To Change Role Of ORI In Response To Council Report

This article is from The Cancer Letter archive.

Vol. 25 No. 46 | December 3, 1999

Download PDF Visit The Full Archive

Related Articles

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Vaccine Increases PFS 146%, OS 60% In Phase II Clinical Trial

May 31, 2013

NCI, SAIC To Support Contracts For Molecular Target Labs.

February 25, 2000

Cooperative Group Chairmen Told They Must Do Their Own Planning, Will Get Funds Increase

September 26, 1975

DRCCA Board Approves Concepts Of Four New Antismoking Projects

May 20, 1983

NCAB, De Vita Rap Tobacco Industry For Targeting Blacks, Hispanics

October 24, 1986